(Q35642422)

9 August 2017

Quantitation of ciprofloxacin in body fluids by high-pressure liquid chromatography (English)

1 reference

9 August 2017

A Weber

1

1 reference

9 August 2017

D Chaffin

series ordinal

2

1 reference

9 August 2017

A Smith

series ordinal

3

1 reference

9 August 2017

K E Opheim

series ordinal

4

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 April 1985

1 reference

Antimicrobial Agents and Chemotherapy

9 August 2017

1 reference

9 August 2017

27

1 reference

9 August 2017

531-534

1 reference

9 August 2017

4

1 reference

In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent

9 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180090

Pharmacokinetics and tissue penetration of ciprofloxacin

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180090

Pharmacokinetics of intravenously administered ciprofloxacin

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180090

Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180090

In vitro activity of ciprofloxacin (Bay o 9867)

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180090

Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180090

Norfioxacin (MK–0366) treatment of urinary tract infections in hospitalized patients

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180090

In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180090

Activity of ciprofloxacin (BAYo 9867) against Pseudomonas aeruginosa and ampicillin-resistant Enterobacteriaceae

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180090

In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid

25 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3159337

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.27.4.531

1 reference

9 August 2017

1 reference

9 August 2017

1 reference